Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Administration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04208412
What this trial is testing

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 84
Testing effectiveness (Phase 2)Looking for participantsNCT06158269
What this trial is testing

DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 40
Early research (Phase 1)Study completedNCT02401295
What this trial is testing

ATRA, Celecoxib, and Itraconazole as Maintenance

Who this might be right for
Relapsed Multiple Myeloma
University of Iowa 1
Post-approval studies (Phase 4)Ended earlyNCT00981773
What this trial is testing

The St. Marys and The Mater Switch Study

Who this might be right for
HIV Infections
Imperial College London 18
Early research (Phase 1)Looking for participantsNCT07369895
What this trial is testing

Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
O&D BioTech Group CO., Limited 18
Testing effectiveness (Phase 2)Looking for participantsNCT05092451
What this trial is testing

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Who this might be right for
B-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more
M.D. Anderson Cancer Center 80
Not applicableStudy completedNCT00984451
What this trial is testing

A Pilot Study for Collection of Anti-Influenza A Immune Plasma

Who this might be right for
Influenza A Virus InfectionSwine Flu
National Institute of Allergy and Infectious Diseases (NIAID) 102
Not applicableLooking for participantsNCT06205953
What this trial is testing

A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)

Who this might be right for
AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 400
Not applicableNot Yet RecruitingNCT07013656
What this trial is testing

Effects of Combined Administration of Calcium and L-tryptophan on Gut Functions and Blood Glucose in Healthy Humans

Who this might be right for
Healthy
University of Adelaide 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344
What this trial is testing

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 53
Not applicableStudy completedNCT03197428
What this trial is testing

Platelet-rich Plasma for Chronic Lateral Ankle Instability

Who this might be right for
Ankle InstabilityPlatelet-rich Plasma
Pei-Yuan Lee, MD 20
Not applicableActive Not RecruitingNCT04142372
What this trial is testing

Tissue Microarray of Hematological Malignancies

Who this might be right for
Hematological Malignancies
Tampere University Hospital 5,000
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Early research (Phase 1)Study completedNCT04554992
What this trial is testing

Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)

Who this might be right for
Covid19
The Methodist Hospital Research Institute 350
Not applicableLooking for participantsNCT05245136
What this trial is testing

Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.

Who this might be right for
Characteristics DiseaseMetastatic CancerSolid Tumor
University Hospital Augsburg 3,000
Early research (Phase 1)Ended earlyNCT01045863
What this trial is testing

To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers

Who this might be right for
Healthy
Pfizer 10
Post-approval studies (Phase 4)Study completedNCT00741663
What this trial is testing

Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)

Who this might be right for
CirrhosisAscites
University of Padova 100
Large-scale testing (Phase 3)Study completedNCT03901963
What this trial is testing

Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 200
Not applicableLooking for participantsNCT07565844
What this trial is testing

Intradermal Exosomes, Platelet-Rich Plasma, and Steroids for Post-Herpetic Neuralgia

Who this might be right for
Postherpetic Neuralgia ( PHN )
Zagazig University 45
Testing effectiveness (Phase 2)Study completedNCT00532844
What this trial is testing

A Phase 2, Pharmacokinetic (PK) Study of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction

Who this might be right for
Endothelial Dysfunction
BioMarin Pharmaceutical 52
Next Page